TABLE 1 Global Repeat Expansion Disorders Treatment Market By Disorders, 2024-2034, USD (Million)
TABLE 2 Global Repeat Expansion Disorders Treatment Market By Spinal and Bulbar Muscular Atrophy/Kennedy’s Disease, 2024-2034, USD (Million)
TABLE 3 Global Repeat Expansion Disorders Treatment Market By Myotonic dystrophy, 2024-2034, USD (Million)
TABLE 4 Global Repeat Expansion Disorders Treatment Market By Route of Administration, 2024-2034, USD (Million)
TABLE 5 Global Repeat Expansion Disorders Treatment Market By Distribution Channel, 2024-2034, USD (Million)
TABLE 6 Global Repeat Expansion Disorders Treatment Market By Drug Pipeline (Profile), 2024-2034, USD (Million)
TABLE 7 North America Repeat Expansion Disorders Treatment Market By Disorders, 2024-2034, USD (Million)
TABLE 8 North America Repeat Expansion Disorders Treatment Market By Spinal and Bulbar Muscular Atrophy/Kennedy’s Disease, 2024-2034, USD (Million)
TABLE 9 North America Repeat Expansion Disorders Treatment Market By Myotonic dystrophy, 2024-2034, USD (Million)
TABLE 10 North America Repeat Expansion Disorders Treatment Market By Route of Administration, 2024-2034, USD (Million)
TABLE 11 North America Repeat Expansion Disorders Treatment Market By Distribution Channel, 2024-2034, USD (Million)
TABLE 12 North America Repeat Expansion Disorders Treatment Market By Drug Pipeline (Profile), 2024-2034, USD (Million)
TABLE 13 U.S. Repeat Expansion Disorders Treatment Market By Disorders, 2024-2034, USD (Million)
TABLE 14 U.S. Repeat Expansion Disorders Treatment Market By Spinal and Bulbar Muscular Atrophy/Kennedy’s Disease, 2024-2034, USD (Million)
TABLE 15 U.S. Repeat Expansion Disorders Treatment Market By Myotonic dystrophy, 2024-2034, USD (Million)
TABLE 16 U.S. Repeat Expansion Disorders Treatment Market By Route of Administration, 2024-2034, USD (Million)
TABLE 17 U.S. Repeat Expansion Disorders Treatment Market By Distribution Channel, 2024-2034, USD (Million)
TABLE 18 U.S. Repeat Expansion Disorders Treatment Market By Drug Pipeline (Profile), 2024-2034, USD (Million)
TABLE 19 Canada Repeat Expansion Disorders Treatment Market By Disorders, 2024-2034, USD (Million)
TABLE 20 Canada Repeat Expansion Disorders Treatment Market By Spinal and Bulbar Muscular Atrophy/Kennedy’s Disease, 2024-2034, USD (Million)
TABLE 21 Canada Repeat Expansion Disorders Treatment Market By Myotonic dystrophy, 2024-2034, USD (Million)
TABLE 22 Canada Repeat Expansion Disorders Treatment Market By Route of Administration, 2024-2034, USD (Million)
TABLE 23 Canada Repeat Expansion Disorders Treatment Market By Distribution Channel, 2024-2034, USD (Million)
TABLE 24 Canada Repeat Expansion Disorders Treatment Market By Drug Pipeline (Profile), 2024-2034, USD (Million)
TABLE 25 Rest of North America Repeat Expansion Disorders Treatment Market By Disorders, 2024-2034, USD (Million)
TABLE 26 Rest of North America Repeat Expansion Disorders Treatment Market By Spinal and Bulbar Muscular Atrophy/Kennedy’s Disease, 2024-2034, USD (Million)
TABLE 27 Rest of North America Repeat Expansion Disorders Treatment Market By Myotonic dystrophy, 2024-2034, USD (Million)
TABLE 28 Rest of North America Repeat Expansion Disorders Treatment Market By Route of Administration, 2024-2034, USD (Million)
TABLE 29 Rest of North America Repeat Expansion Disorders Treatment Market By Distribution Channel, 2024-2034, USD (Million)
TABLE 30 Rest of North America Repeat Expansion Disorders Treatment Market By Drug Pipeline (Profile), 2024-2034, USD (Million)
TABLE 31 UK and European Union Repeat Expansion Disorders Treatment Market By Disorders, 2024-2034, USD (Million)
TABLE 32 UK and European Union Repeat Expansion Disorders Treatment Market By Spinal and Bulbar Muscular Atrophy/Kennedy’s Disease, 2024-2034, USD (Million)
TABLE 33 UK and European Union Repeat Expansion Disorders Treatment Market By Myotonic dystrophy, 2024-2034, USD (Million)
TABLE 34 UK and European Union Repeat Expansion Disorders Treatment Market By Route of Administration, 2024-2034, USD (Million)
TABLE 35 UK and European Union Repeat Expansion Disorders Treatment Market By Distribution Channel, 2024-2034, USD (Million)
TABLE 36 UK and European Union Repeat Expansion Disorders Treatment Market By Drug Pipeline (Profile), 2024-2034, USD (Million)
TABLE 37 UK Repeat Expansion Disorders Treatment Market By Disorders, 2024-2034, USD (Million)
TABLE 38 UK Repeat Expansion Disorders Treatment Market By Spinal and Bulbar Muscular Atrophy/Kennedy’s Disease, 2024-2034, USD (Million)
TABLE 39 UK Repeat Expansion Disorders Treatment Market By Myotonic dystrophy, 2024-2034, USD (Million)
TABLE 40 UK Repeat Expansion Disorders Treatment Market By Route of Administration, 2024-2034, USD (Million)
TABLE 41 UK Repeat Expansion Disorders Treatment Market By Distribution Channel, 2024-2034, USD (Million)
TABLE 42 UK Repeat Expansion Disorders Treatment Market By Drug Pipeline (Profile), 2024-2034, USD (Million)
TABLE 43 Germany Repeat Expansion Disorders Treatment Market By Disorders, 2024-2034, USD (Million)
TABLE 44 Germany Repeat Expansion Disorders Treatment Market By Spinal and Bulbar Muscular Atrophy/Kennedy’s Disease, 2024-2034, USD (Million)
TABLE 45 Germany Repeat Expansion Disorders Treatment Market By Myotonic dystrophy, 2024-2034, USD (Million)
TABLE 46 Germany Repeat Expansion Disorders Treatment Market By Route of Administration, 2024-2034, USD (Million)
TABLE 47 Germany Repeat Expansion Disorders Treatment Market By Distribution Channel, 2024-2034, USD (Million)
TABLE 48 Germany Repeat Expansion Disorders Treatment Market By Drug Pipeline (Profile), 2024-2034, USD (Million)
TABLE 49 Spain Repeat Expansion Disorders Treatment Market By Disorders, 2024-2034, USD (Million)
TABLE 50 Spain Repeat Expansion Disorders Treatment Market By Spinal and Bulbar Muscular Atrophy/Kennedy’s Disease, 2024-2034, USD (Million)
TABLE 51 Spain Repeat Expansion Disorders Treatment Market By Myotonic dystrophy, 2024-2034, USD (Million)
TABLE 52 Spain Repeat Expansion Disorders Treatment Market By Route of Administration, 2024-2034, USD (Million)
TABLE 53 Spain Repeat Expansion Disorders Treatment Market By Distribution Channel, 2024-2034, USD (Million)
TABLE 54 Spain Repeat Expansion Disorders Treatment Market By Drug Pipeline (Profile), 2024-2034, USD (Million)
TABLE 55 Italy Repeat Expansion Disorders Treatment Market By Disorders, 2024-2034, USD (Million)
TABLE 56 Italy Repeat Expansion Disorders Treatment Market By Spinal and Bulbar Muscular Atrophy/Kennedy’s Disease, 2024-2034, USD (Million)
TABLE 57 Italy Repeat Expansion Disorders Treatment Market By Myotonic dystrophy, 2024-2034, USD (Million)
TABLE 58 Italy Repeat Expansion Disorders Treatment Market By Route of Administration, 2024-2034, USD (Million)
TABLE 59 Italy Repeat Expansion Disorders Treatment Market By Distribution Channel, 2024-2034, USD (Million)
TABLE 60 Italy Repeat Expansion Disorders Treatment Market By Drug Pipeline (Profile), 2024-2034, USD (Million)
TABLE 61 France Repeat Expansion Disorders Treatment Market By Disorders, 2024-2034, USD (Million)
TABLE 62 France Repeat Expansion Disorders Treatment Market By Spinal and Bulbar Muscular Atrophy/Kennedy’s Disease, 2024-2034, USD (Million)
TABLE 63 France Repeat Expansion Disorders Treatment Market By Myotonic dystrophy, 2024-2034, USD (Million)
TABLE 64 France Repeat Expansion Disorders Treatment Market By Route of Administration, 2024-2034, USD (Million)
TABLE 65 France Repeat Expansion Disorders Treatment Market By Distribution Channel, 2024-2034, USD (Million)
TABLE 66 France Repeat Expansion Disorders Treatment Market By Drug Pipeline (Profile), 2024-2034, USD (Million)
TABLE 67 Rest of Europe Repeat Expansion Disorders Treatment Market By Disorders, 2024-2034, USD (Million)
TABLE 68 Rest of Europe Repeat Expansion Disorders Treatment Market By Spinal and Bulbar Muscular Atrophy/Kennedy’s Disease, 2024-2034, USD (Million)
TABLE 69 Rest of Europe Repeat Expansion Disorders Treatment Market By Myotonic dystrophy, 2024-2034, USD (Million)
TABLE 70 Rest of Europe Repeat Expansion Disorders Treatment Market By Route of Administration, 2024-2034, USD (Million)
TABLE 71 Rest of Europe Repeat Expansion Disorders Treatment Market By Distribution Channel, 2024-2034, USD (Million)
TABLE 72 Rest of Europe Repeat Expansion Disorders Treatment Market By Drug Pipeline (Profile), 2024-2034, USD (Million)
TABLE 73 Asia Repeat Expansion Disorders Treatment Market By Disorders, 2024-2034, USD (Million)
TABLE 74 Asia Repeat Expansion Disorders Treatment Market By Spinal and Bulbar Muscular Atrophy/Kennedy’s Disease, 2024-2034, USD (Million)
TABLE 75 Asia Repeat Expansion Disorders Treatment Market By Myotonic dystrophy, 2024-2034, USD (Million)
TABLE 76 Asia Repeat Expansion Disorders Treatment Market By Route of Administration, 2024-2034, USD (Million)
TABLE 77 Asia Repeat Expansion Disorders Treatment Market By Distribution Channel, 2024-2034, USD (Million)
TABLE 78 Asia Repeat Expansion Disorders Treatment Market By Drug Pipeline (Profile), 2024-2034, USD (Million)
TABLE 79 China Repeat Expansion Disorders Treatment Market By Disorders, 2024-2034, USD (Million)
TABLE 80 China Repeat Expansion Disorders Treatment Market By Spinal and Bulbar Muscular Atrophy/Kennedy’s Disease, 2024-2034, USD (Million)
TABLE 81 China Repeat Expansion Disorders Treatment Market By Myotonic dystrophy, 2024-2034, USD (Million)
TABLE 82 China Repeat Expansion Disorders Treatment Market By Route of Administration, 2024-2034, USD (Million)
TABLE 83 China Repeat Expansion Disorders Treatment Market By Distribution Channel, 2024-2034, USD (Million)
TABLE 84 China Repeat Expansion Disorders Treatment Market By Drug Pipeline (Profile), 2024-2034, USD (Million)
TABLE 85 Japan Repeat Expansion Disorders Treatment Market By Disorders, 2024-2034, USD (Million)
TABLE 86 Japan Repeat Expansion Disorders Treatment Market By Spinal and Bulbar Muscular Atrophy/Kennedy’s Disease, 2024-2034, USD (Million)
TABLE 87 Japan Repeat Expansion Disorders Treatment Market By Myotonic dystrophy, 2024-2034, USD (Million)
TABLE 88 Japan Repeat Expansion Disorders Treatment Market By Route of Administration, 2024-2034, USD (Million)
TABLE 89 Japan Repeat Expansion Disorders Treatment Market By Distribution Channel, 2024-2034, USD (Million)
TABLE 90 Japan Repeat Expansion Disorders Treatment Market By Drug Pipeline (Profile), 2024-2034, USD (Million)
TABLE 91 India Repeat Expansion Disorders Treatment Market By Disorders, 2024-2034, USD (Million)
TABLE 92 India Repeat Expansion Disorders Treatment Market By Spinal and Bulbar Muscular Atrophy/Kennedy’s Disease, 2024-2034, USD (Million)
TABLE 93 India Repeat Expansion Disorders Treatment Market By Myotonic dystrophy, 2024-2034, USD (Million)
TABLE 94 India Repeat Expansion Disorders Treatment Market By Route of Administration, 2024-2034, USD (Million)
TABLE 95 India Repeat Expansion Disorders Treatment Market By Distribution Channel, 2024-2034, USD (Million)
TABLE 96 India Repeat Expansion Disorders Treatment Market By Drug Pipeline (Profile), 2024-2034, USD (Million)
TABLE 97 Australia Repeat Expansion Disorders Treatment Market By Disorders, 2024-2034, USD (Million)
TABLE 98 Australia Repeat Expansion Disorders Treatment Market By Spinal and Bulbar Muscular Atrophy/Kennedy’s Disease, 2024-2034, USD (Million)
TABLE 99 Australia Repeat Expansion Disorders Treatment Market By Myotonic dystrophy, 2024-2034, USD (Million)
TABLE 100 Australia Repeat Expansion Disorders Treatment Market By Route of Administration, 2024-2034, USD (Million)
TABLE 101 Australia Repeat Expansion Disorders Treatment Market By Distribution Channel, 2024-2034, USD (Million)
TABLE 102 Australia Repeat Expansion Disorders Treatment Market By Drug Pipeline (Profile), 2024-2034, USD (Million)
TABLE 103 South Korea Repeat Expansion Disorders Treatment Market By Disorders, 2024-2034, USD (Million)
TABLE 104 South Korea Repeat Expansion Disorders Treatment Market By Spinal and Bulbar Muscular Atrophy/Kennedy’s Disease, 2024-2034, USD (Million)
TABLE 105 South Korea Repeat Expansion Disorders Treatment Market By Myotonic dystrophy, 2024-2034, USD (Million)
TABLE 106 South Korea Repeat Expansion Disorders Treatment Market By Route of Administration, 2024-2034, USD (Million)
TABLE 107 South Korea Repeat Expansion Disorders Treatment Market By Distribution Channel, 2024-2034, USD (Million)
TABLE 108 South Korea Repeat Expansion Disorders Treatment Market By Drug Pipeline (Profile), 2024-2034, USD (Million)
TABLE 109 Latin America Repeat Expansion Disorders Treatment Market By Disorders, 2024-2034, USD (Million)
TABLE 110 Latin America Repeat Expansion Disorders Treatment Market By Spinal and Bulbar Muscular Atrophy/Kennedy’s Disease, 2024-2034, USD (Million)
TABLE 111 Latin America Repeat Expansion Disorders Treatment Market By Myotonic dystrophy, 2024-2034, USD (Million)
TABLE 112 Latin America Repeat Expansion Disorders Treatment Market By Route of Administration, 2024-2034, USD (Million)
TABLE 113 Latin America Repeat Expansion Disorders Treatment Market By Distribution Channel, 2024-2034, USD (Million)
TABLE 114 Latin America Repeat Expansion Disorders Treatment Market By Drug Pipeline (Profile), 2024-2034, USD (Million)
TABLE 115 Brazil Repeat Expansion Disorders Treatment Market By Disorders, 2024-2034, USD (Million)
TABLE 116 Brazil Repeat Expansion Disorders Treatment Market By Spinal and Bulbar Muscular Atrophy/Kennedy’s Disease, 2024-2034, USD (Million)
TABLE 117 Brazil Repeat Expansion Disorders Treatment Market By Myotonic dystrophy, 2024-2034, USD (Million)
TABLE 118 Brazil Repeat Expansion Disorders Treatment Market By Route of Administration, 2024-2034, USD (Million)
TABLE 119 Brazil Repeat Expansion Disorders Treatment Market By Distribution Channel, 2024-2034, USD (Million)
TABLE 120 Brazil Repeat Expansion Disorders Treatment Market By Drug Pipeline (Profile), 2024-2034, USD (Million)
TABLE 121 Mexico Repeat Expansion Disorders Treatment Market By Disorders, 2024-2034, USD (Million)
TABLE 122 Mexico Repeat Expansion Disorders Treatment Market By Spinal and Bulbar Muscular Atrophy/Kennedy’s Disease, 2024-2034, USD (Million)
TABLE 123 Mexico Repeat Expansion Disorders Treatment Market By Myotonic dystrophy, 2024-2034, USD (Million)
TABLE 124 Mexico Repeat Expansion Disorders Treatment Market By Route of Administration, 2024-2034, USD (Million)
TABLE 125 Mexico Repeat Expansion Disorders Treatment Market By Distribution Channel, 2024-2034, USD (Million)
TABLE 126 Mexico Repeat Expansion Disorders Treatment Market By Drug Pipeline (Profile), 2024-2034, USD (Million)
TABLE 127 Rest of Latin America Repeat Expansion Disorders Treatment Market By Disorders, 2024-2034, USD (Million)
TABLE 128 Rest of Latin America Repeat Expansion Disorders Treatment Market By Spinal and Bulbar Muscular Atrophy/Kennedy’s Disease, 2024-2034, USD (Million)
TABLE 129 Rest of Latin America Repeat Expansion Disorders Treatment Market By Myotonic dystrophy, 2024-2034, USD (Million)
TABLE 130 Rest of Latin America Repeat Expansion Disorders Treatment Market By Route of Administration, 2024-2034, USD (Million)
TABLE 131 Rest of Latin America Repeat Expansion Disorders Treatment Market By Distribution Channel, 2024-2034, USD (Million)
TABLE 132 Rest of Latin America Repeat Expansion Disorders Treatment Market By Drug Pipeline (Profile), 2024-2034, USD (Million)
TABLE 133 Middle East and Africa Repeat Expansion Disorders Treatment Market By Disorders, 2024-2034, USD (Million)
TABLE 134 Middle East and Africa Repeat Expansion Disorders Treatment Market By Spinal and Bulbar Muscular Atrophy/Kennedy’s Disease, 2024-2034, USD (Million)
TABLE 135 Middle East and Africa Repeat Expansion Disorders Treatment Market By Myotonic dystrophy, 2024-2034, USD (Million)
TABLE 136 Middle East and Africa Repeat Expansion Disorders Treatment Market By Route of Administration, 2024-2034, USD (Million)
TABLE 137 Middle East and Africa Repeat Expansion Disorders Treatment Market By Distribution Channel, 2024-2034, USD (Million)
TABLE 138 Middle East and Africa Repeat Expansion Disorders Treatment Market By Drug Pipeline (Profile), 2024-2034, USD (Million)
TABLE 139 GCC Repeat Expansion Disorders Treatment Market By Disorders, 2024-2034, USD (Million)
TABLE 140 GCC Repeat Expansion Disorders Treatment Market By Spinal and Bulbar Muscular Atrophy/Kennedy’s Disease, 2024-2034, USD (Million)
TABLE 141 GCC Repeat Expansion Disorders Treatment Market By Myotonic dystrophy, 2024-2034, USD (Million)
TABLE 142 GCC Repeat Expansion Disorders Treatment Market By Route of Administration, 2024-2034, USD (Million)
TABLE 143 GCC Repeat Expansion Disorders Treatment Market By Distribution Channel, 2024-2034, USD (Million)
TABLE 144 GCC Repeat Expansion Disorders Treatment Market By Drug Pipeline (Profile), 2024-2034, USD (Million)
TABLE 145 Africa Repeat Expansion Disorders Treatment Market By Disorders, 2024-2034, USD (Million)
TABLE 146 Africa Repeat Expansion Disorders Treatment Market By Spinal and Bulbar Muscular Atrophy/Kennedy’s Disease, 2024-2034, USD (Million)
TABLE 147 Africa Repeat Expansion Disorders Treatment Market By Myotonic dystrophy, 2024-2034, USD (Million)
TABLE 148 Africa Repeat Expansion Disorders Treatment Market By Route of Administration, 2024-2034, USD (Million)
TABLE 149 Africa Repeat Expansion Disorders Treatment Market By Distribution Channel, 2024-2034, USD (Million)
TABLE 150 Africa Repeat Expansion Disorders Treatment Market By Drug Pipeline (Profile), 2024-2034, USD (Million)
TABLE 151 Rest of Middle East and Africa Repeat Expansion Disorders Treatment Market By Disorders, 2024-2034, USD (Million)
TABLE 152 Rest of Middle East and Africa Repeat Expansion Disorders Treatment Market By Spinal and Bulbar Muscular Atrophy/Kennedy’s Disease, 2024-2034, USD (Million)
TABLE 153 Rest of Middle East and Africa Repeat Expansion Disorders Treatment Market By Myotonic dystrophy, 2024-2034, USD (Million)
TABLE 154 Rest of Middle East and Africa Repeat Expansion Disorders Treatment Market By Route of Administration, 2024-2034, USD (Million)
TABLE 155 Rest of Middle East and Africa Repeat Expansion Disorders Treatment Market By Distribution Channel, 2024-2034, USD (Million)
TABLE 156 Rest of Middle East and Africa Repeat Expansion Disorders Treatment Market By Drug Pipeline (Profile), 2024-2034, USD (Million)